Arkolith/Insider Trading/BMRN/Form 4

Hubbard Cristin

EVP, Chief Commercial OfficerBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed May 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2025Sell(S)273$64.92$18K33K
Apr 30, 2025Grant(A)273$54.14$15K33K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001048477-25-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML